Axim has 5(five) ongoing or recently completed oncology studies of various sorts. These provide a host of possible near term catalysts. One was started a year ago before Axim owned Sapphire and is wrapping Up now. Others are likely too.
Sergei has been awarded several grants for research One of them was for searching for a bio marker for Autism.
This guys whole life has revolves around research and practical applications surrounding areas that overlap with these niches.
One can suggest that the company is doing this for publicity but they kept their patent application and work on Covid secret for MONTHS.
That was a strategic decision That supports their IP and their diligence,
And Could have helped The stock then
But clearly the science and resultant possible benefits are where these guys are headed.
Imo they are doing things right.
The company pivoted with the Sapphire opportunity, and I’m glad they did.
News 
Market Data 
Discover 
